Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/fb9d116e-ec5e-4a26-85b5-963b7ccfb38d/

LXEO

Lexeo Therapeutics, Inc. Common Stock
Chart
$4.37
Latest Week 2026-06-05
HealthcareBiotechnologySMALL
Snapshot 2026-06-07 · 0.0w · Fresh
0.46
OS Score
47.0%
Value
46.0%
Quality
46.0%
Momentum
3/9
F-Score
0.465
QV
StrategiesValueQualityMomentumCompositeInteractionsFactor AnalysisTrendsFundamentals
Strategy Eligibility
1 of 23 passing
★
OS Composite
✗
↗
Trending Value
✗
◆
Quality × Value
✗
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
✗
◇
VC2 Cheapest
✗
📐
EBITDA/EV
✗
◐
Veiled Value
✗
▣
Piotroski Bargains
✗
🔬
Quality Compounders
✗
📈
Consistent Earners
Noneyr
🌱
GARP
✗
🔄
Shareholder Yield
✗
💰
High Yield
✗
🚀
Momentum Leaders
✗
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
✗
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
✗
⚡
Risk-Adj Momentum
✗
V
Value Analysis
Cheapness relative to fundamentals
47.0%ile
P/B
1.5×
FCF Yield
-0.341
SH Yield
0.000
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
54.00000000
/100 — 1=cheapest
VC2 (Trending Value)
54.00000000
/100
VC3 (Buyback)
54.00000000
/100
Negative FCF yield (-34.1%) — the business is currently cash-consumptive.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
46.0%ile
ROE
-0.378
ROA
-0.350
GPA
-0.008
D/E
0.08
Current
14.16
F-Score
3/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Stability
0.192
lower=better
Accruals
0.042
lower=better
5yr Consist
Yes
Conservative balance sheet with D/E of 0.08.
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
46.0%ile
6M Return
-53.3%
12M Return
12.6%
12-1 Mom
50.3%
Risk-Adj
0.67
Vol 252d
75.1%
Vol 60d
186.4%
↑ Expanding
Max DD 12M
-58.5%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
12-1 momentum of 50% is very strong — a clear uptrend. Near-term vol (186%) is expanding vs long-term (75%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.46
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare · 500 peers
Sector Value %ile
20.4%
Sector Quality %ile
19.4%
P/B z-score
-0.29
Sector Avg OS
63.3%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
IRWD Ironwood Pharmaceuticals Inc 99.0% 93.0% 86.0% 98.0%
RIGL Rigel Pharmaceuticals Inc 98.0% 94.0% 92.0% 76.0%
FBIO Fortress Biotech Inc 98.0% 97.0% 93.0% 74.0%
PBYI Puma Biotechnology Inc 97.0% 80.0% 97.0% 92.0%
WW WW International, Inc. Common Stock 97.0% 88.0% 80.0% 99.0%
CGEN Compugen 97.0% 90.0% 95.0% 76.0%
FBIOP Fortress Biotech Inc Pref Series A 97.0% 81.0% 95.0% 90.0%
MD Mednax Inc 96.0% 87.0% 80.0% 87.0%
Factor Interactions
Volatility Expanding
60-day vol (186%) significantly exceeds 252-day (75%). Near-term risk is elevated.
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
D
32.4% avg (3 factors)
Quality
D
40.2% avg (6 factors)
Momentum
C
47.3% avg (4 factors)
Risk
F
0.0% avg (1 factors)
Elevated risk profile — position sizing should reflect the higher volatility.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Factor Persistence1 snapshots
FactorCurrentStreakTrendSpark
OS Composite0.460—0—
Value %ile0.470—0—
Quality %ile0.460—0—
Momentum %ile0.460—0—
F-Score3.000—1—
Confidence0.697—0—
Volatility0.751—1—
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
Price / Book
1.53
FCF Yield
-34.1%
Shareholder Yield
Div + net buyback / mktcap
0.0%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
-37.8%
Return on Assets
-35.0%
Gross Profit / Assets
Novy-Marx GPA
-0.8%
Debt / Equity
0.08
Current Ratio
14.16
Accruals Ratio
(NI-OCF)/Assets — lower=better
0.042
MomentumPrice trend strength over different horizons
6M Return
-53.3%
12M Return
12.6%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
50.3%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
0.67
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Earnings Stability (CV)
Lower = more stable
0.192
5yr Consistent
EPS up every year for 5 years
Yes
Piotroski F-Score
3
Dividend Yield
0.0%
Buyback Yield
0.0%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
54
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
54
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
54
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity